secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fulcrum Therapeutics, Inc. (FULC)
CIK:        0001680581
Form:       8-K
Filed at:   2022-08-23T23:59:59+00:00
Accession:  0001193125-22-227590
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Fulcrum Therapeutics completes $80.9M underwritten public offering
------------------------------------------------------------------

- Underwriters exercised option to buy 1,438,618 additional shares at $7.82/share.
- Additional net proceeds of ~$10.6M; total net proceeds ~$80.9M after discounts and expenses.
- Overallotment option closed on August 23, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680581/000119312522227590/0001193125-22-227590-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680581/000119312522227590/d353295d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-227590

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer